TG acts in Diploma Plc acquisition of Abacus ALS Pty Ltd

22 May 2017


Partner, Roberta Bozzoli, and Lawyer, Thomas Honeywill, acted for the shareholders of Abacus ALS Pty Ltd (Abacus), a pathology, life science, medical device and healthcare distribution company operating internationally, in the acquisition of Abacus shares by Diploma Australia Healthcare Pty Ltd (Diploma) for approximately $22.5 million.

Diploma is a subsidiary of Diploma PLC, a British FTSE 250 Index company which operates globally in the sectors of life sciences, seals and controls. The acquisition involved complex and lengthy negotiations between an international group of parties and ultimately was successful in providing our clients with the significant sale outcome.

This article published to Corporate Livewire gives greater information about the transaction if you would like to read more: